My watch list  

Recently acquired by AstraZeneca, Arrow Therapeutics is a fully integrated private drug discovery, research and development company focused on antiviral therapies in areas of significant unmet medical need.

Within our focus on antiviral therapies, Arrow specialises in small molecule drugs with novel mechanisms of action and has a number of research and development programs, the most advanced of which target Respiratory Syncytial Virus (RSV) and Hepatitis C Virus (HCV).

More about Arrow Therapeutics
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE